Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 17;8(10):e76417.
doi: 10.1371/journal.pone.0076417. eCollection 2013.

Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study

Miguel Á Salinero-Fort  1 , Francisco Javier San Andrés-Rebollo, Carmen de Burgos-Lunar, Francisco Jesús Arrieta-Blanco, Paloma Gómez-Campelo; MADIABETES Group
Collaborators, Affiliations

Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study

Miguel Á Salinero-Fort et al. PLoS One. .

Abstract

Objective: To evaluate the incidence of diabetic retinopathy in patients with Type 2 Diabetes Mellitus, to identify the risk factors associated with the incidence of retinopathy and to develop a risk table to predict four-year retinopathy risk stratification for clinical use, from a four-year cohort study.

Design: The MADIABETES Study is a prospective cohort study of 3,443 outpatients with Type 2 Diabetes Mellitus, sampled from 56 primary health care centers (131 general practitioners) in Madrid (Spain).

Results: The cumulative incidence of retinopathy at four-year follow-up was 8.07% (95% CI = 7.04-9.22) and the incidence density was 2.03 (95% CI = 1.75-2.33) cases per 1000 patient-months or 2.43 (95% CI = 2.10-2.80) cases per 100 patient-years. The highest adjusted hazard ratios of associated risk factors for incidence of diabetic retinopathy were LDL-C >190 mg/dl (HR = 7.91; 95% CI = 3.39-18.47), duration of diabetes longer than 22 years (HR = 2.00; 95% CI = 1.18-3.39), HbA1c>8% (HR = 1.90; 95% CI = 1.30-2.77), and aspirin use (HR = 1.65; 95% CI = 1.22-2.24). Microalbuminuria (HR = 1.17; 95% CI = 0.75-1.82) and being female (HR = 1.12; 95% CI = 0.84-1.49) showed a non-significant increase of diabetic retinopathy. The greatest risk is observed in females who had diabetes for more than 22 years, with microalbuminuria, HbA1c>8%, hypertension, LDL-Cholesterol >190 mg/dl and aspirin use.

Conclusions: After a four-year follow-up, the cumulative incidence of retinopathy was relatively low in comparison with other studies. Higher baseline HbA1c, aspirin use, higher LDL-Cholesterol levels, and longer duration of diabetes were the only statistically significant risk factors found for diabetic retinopathy incidence. This is the first study to demonstrate an association between aspirin use and diabetic retinopathy risk in a well-defined cohort of patients with Type 2 Diabetes Mellitus at low risk of cardiovascular events. However, further studies with patients at high cardiovascular and metabolic risk are needed to clarify this issue.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flow diagram of the MADIABETES cohort.
See this image and copyright information in PMC

References

    1. Shotliff K, Davies N (2012) Diabetes and the Eye. In: Shaw KM, Cummings MH, editors. Diabetes. Oxford, UK: Wiley-Blackwell. 1–33. doi: 10.1002/9781118405550.ch1
    1. Moss SE, Klein R, Klein BE (1998) The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105(6): 998–1003. - PubMed
    1. Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, et al. (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82(11): 844–851. - PMC - PubMed
    1. American Diabetes Association (2011) Standards of Medical Care in Diabetes–2012. Diabetes Care 35(Suppl1): S11–S63. - PMC - PubMed
    1. Thompson JW, Bost J, Ahmed F, Ingalls CE, Sennett C (1998) The NCQA’s quality compass: evaluating managed care in the United States. Health Aff (Millwood) 17(1): 152–158. - PubMed

Publication types